These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7633691)
1. Local nasal immunotherapy. Has the time come? Naclerio RM Am J Respir Crit Care Med; 1995 Aug; 152(2):425-6. PubMed ID: 7633691 [No Abstract] [Full Text] [Related]
2. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. Passalacqua G; Albano M; Ruffoni S; Pronzato C; Riccio AM; Di Berardino L; Scordamaglia A; Canonica GW Am J Respir Crit Care Med; 1995 Aug; 152(2):461-6. PubMed ID: 7633693 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. Dahl R; Kapp A; Colombo G; de Monchy JG; Rak S; Emminger W; Rivas MF; Ribel M; Durham SR J Allergy Clin Immunol; 2006 Aug; 118(2):434-40. PubMed ID: 16890769 [TBL] [Abstract][Full Text] [Related]
5. Monoid sublingual immunotherapy. Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe. Cox L; Calderon MA Curr Med Res Opin; 2010 Dec; 26(12):2723-33. PubMed ID: 20979432 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects. Passalacqua G; Albano M; Pronzato C; Riccio AM; Scordamaglia A; Falagiani P; Canonica GW Clin Exp Allergy; 1997 Aug; 27(8):904-8. PubMed ID: 9291287 [TBL] [Abstract][Full Text] [Related]
8. Multiallergen immunotherapy for allergic rhinitis and asthma. Nelson HS J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653 [TBL] [Abstract][Full Text] [Related]
9. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis. Senna GE; Andri G; Dama AR; Falagiani P; Andri L Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271 [TBL] [Abstract][Full Text] [Related]
10. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Ford SA; Baroody FM; Naclerio RM Rhinol Suppl; 1992; 14():52-6. PubMed ID: 1389403 [No Abstract] [Full Text] [Related]
11. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment. Durham SR Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452 [No Abstract] [Full Text] [Related]
16. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Durham SR; Riis B Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075 [TBL] [Abstract][Full Text] [Related]
17. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice. Campbell DE Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205 [TBL] [Abstract][Full Text] [Related]